Rio Biopharmaceuticals Inc

General

Total Cases3

Active Cases1

Patents--

CourtsD. New Jersey D. Delaware

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/18/24	NOVO NORDISK INC. v. RIO BIOPHARMACEUTICALS, INC. 1:24-CV-00688 ( D. NJ )	STIPULATION AND ORDER OF DISMISSAL. Signed by Chief Judge Renee Marie Bumb on 9/17/2024. (mag) (Entered: 09/18/2024)
09/18/24	NOVO NORDISK INC. v. RIO BIOPHARMACEUTICALS, INC. 1:24-CV-00688 ( D. NJ )	***Civil Case Terminated. (mag) (Entered: 09/18/2024)
09/16/24	NOVO NORDISK INC. v. RIO BIOPHARMACEUTICALS, INC. 1:24-CV-00688 ( D. NJ )	Letter from Plaintiffs to the Hon. Renee Marie Bumb, U.S.D.J.. (LIZZA, CHARLES) (Entered: 09/16/2024)
09/12/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 9/12/2024. (Court Reporter Bonnie Archer.) Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT(nmf) (Entered: 09/12/2024)
09/12/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	ORAL ORDER Rescheduling Hearings: (The Final Pretrial Conference is rescheduled (per the teleconference held today) for 11/18/2024 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 9/12/2024. Associated Cases: 1:22-md-03038-CFC-EGT, 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT(nmf) (Entered: 09/12/2024)
09/12/24	NOVO NORDISK INC. v. RIO BIOPHARMACEUTICALS, INC. 1:24-CV-00688 ( D. NJ )	LETTER ORDER Granting Defendant's [51] consented request for a two-week extension of the Markman-related deadlines; the case schedule is amended as set forth within. Signed by Magistrate Judge Sharon A. King on 9/11/2024. (mag) (Entered: 09/12/2024)
09/11/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	[SEALED] Joint Letter to The Honorable Colm F. Connolly from Stamatios Stamoulis and Travis J. Murray regarding Case Status. (Stamoulis, Stamatios) (Entered: 09/11/2024)
09/11/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	SO ORDERED, re (388 in 1:22-md-03038-CFC-EGT, 338 in 1:22-cv-00294-CFC-EGT, 255 in 1:22-cv-01040-CFC-EGT) Stipulation to Extend Close of Expert Discovery and Daubert Motion Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Scheduling Order Deadlines: Expert Discovery due by 10/9/2024. Signed by Judge Colm F. Connolly on 9/11/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT, 1:22-md-03038-CFC-EGT (kmd) (Entered: 09/11/2024) SO ORDERED, re (388 in 1:22-md-03038-CFC-EGT, 338 in 1:22-cv-00294-CFC-EGT, 255 in 1:22-cv-01040-CFC-EGT) Stipulation to Extend Close of Expert Discovery and Daubert Motion Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Scheduling Order Deadlines: Expert Discovery due by 10/9/2024. Signed by Judge Colm F. Connolly on 9/11/2024. Associated Cases: 1:22-cv-00294-CFC-EGT, 1:22-cv-01040-CFC-EGT, 1:22-md-03038-CFC-EGT (kmd) (Entered: 09/11/2024)
09/11/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	STIPULATION and [Proposed] Order to Extend Close of Expert Discovery and Daubert Motion Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/11/2024)
09/10/24	Novo Nordisk Inc v. Rio Biopharmaceuticals Inc 1:22-CV-00294 ( D. DE )	NOTICE of Appearance by Sara M. Metzler on behalf of Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc. (Metzler, Sara) (Entered: 09/10/2024)